AngioSoma (PK) Stock Price

-0.0003 (-2.07%)
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
AngioSoma Inc (PK) SOAN OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0003 -2.07% 0.0142 16:28:40
Open Price Low Price High Price Close Price Prev Close
0.0145 0.01215 0.0145 0.0142 0.0145
Bid Price Ask Price Spread News
0.0134 0.0142 0.0008 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
191 8,815,105 $ 0.013053 $ 115,064 - 0.0006 - 0.0177
Last Trade Time Type Quantity Stock Price Currency
15:59:24 30,000 $ 0.0142 USD

AngioSoma (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 6.47M 455.49M 12.49M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
88.29k $ - 0.00% - -

more financials information »

AngioSoma (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SOAN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.01070.01770.00920.013468920,542,7760.003532.71%
1 Month0.00650.01770.00530.010403811,637,4310.0077118.46%
3 Months0.006850.01770.004950.00856957,392,1040.00735107.3%
6 Months0.00310.01770.001350.00639499,447,0040.0111358.06%
1 Year0.00420.01770.00060.00398439,017,0590.01238.1%
3 Years0.022140.12650.00060.00579524,272,789-0.00794-35.86%
5 Years0.1850.520.00060.006782,702,790-0.1708-92.32%

AngioSoma (PK) Description

AngioSoma, Inc., is an American biotechnology company originally organized in 2011, headquartered in Houston, Texas with offices in the State of Washington, focused on developing innovative therapies for people with serious and life-threating rare disorders. The Company patented and sold for $10 million of preferred shares a treatment for peripheral artery disease (PAD) called LiprostinTM followed by acquiring an exclusive license for a patented method of treating neurodegenerative diseases such as Multiple Sclerosis by administering a synergistically effective amount of the composition to an individual suffering from neurodegeneration and treating neurodegeneration. We are in discussions with several contract research organizations to assist with our submission of new drug application for global marketing.

Your Recent History
AngioSoma ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.